MAPK3 and cancer: As shown in Fig. 6, it was identified that the downregulation of L1CAM inhibited the intrinsic activation of ERK1/2 in Capan-2 cells, indicating that L1CAM may be involved in cancer cell progression via the p38/ERK1/2 signaling pathway.